Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Dr. Ashish Kamat Interview - BOND-003 Study Results

<< Previous

Bullboard Posts

Next >>

Comment by stocksnbonds458on Jan 09, 2024 2:31pm

202 Views

Post# 35817900

RE:RE:RE:RE:RE:Dr. Ashish Kamat Interview - BOND-003 Study Results

LMAO!! Death, you just set the record for the funniest and yet most erudite post in the history of this TLT Board. Beer it is!! I rarely see posts like riverrow's, as I have most of these knuckleheads on iggy. Ruvidar is best in class and will soon have its day.

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading